# Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis

> **NCT01968382** · PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 57 (actual)

## Conditions studied

- Hepatitis, Alcoholic

## Interventions

- **DRUG:** IMM 124-E (Hyperimmune Bovine Colostrum)
- **DRUG:** Placebo (High protein milk powder)

## Key facts

- **NCT ID:** NCT01968382
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2018-12-22
- **Final completion:** 2018-12-22
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968382, "Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01968382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*